Chronic kidney disease (CKD) has become a global public health problem due to its complex etiology and difficult treatment. CKD affects about 10% of the world's population and can lead to higher risks of cardiovascular disease and death. One of the key links of CKD prevention and treatment is to prevent or delay the progress of CKD. This article summarizes the epidemiology, risk factors, R&D investment and preventive and therapeutic drugs of CKD in order to understand the current situation and new preventive and therapeutic progress of CKD.

chronic kidney disease  /  risk factors  /  research and development investment  /  preventive and therapeutic drugs